Technical Analysis for ALDR - Alder BioPharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade A 18.9 0.16% 0.03
ALDR closed up 0.16 percent on Thursday, October 17, 2019, on 1.67 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Up Up Flat
See historical ALDR trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 1.07%
Pocket Pivot Bullish Swing Setup 1.07%
Volume Surge Other 1.07%
Calm After Storm Range Contraction 1.07%
Narrow Range Bar Range Contraction 1.07%
Parabolic Rise Strength 1.07%
Upper Bollinger Band Walk Strength 1.07%
Inside Day Range Contraction 1.07%
Wide Bands Range Expansion 1.07%
Above Upper BB Strength 1.07%

Older signals for ALDR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Alder Biopharmaceuticals Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes various therapeutic antibodies in the United States and Australia. It is developing monoclonal antibodies comprising ALD403, which has completed Phase Ib proof-of-concept trials to target calcitonin gene-related peptide for the prevention of migraine; and Clazakizumab that has completed Phase IIb clinical trials that inhibits the pro-inflammatory cytokine interleukin-6 in the treatment of rheumatoid arthritis and psoriatic arthritis. The company also has preclinical programs in the discovery phase for various indications. Alder Biopharmaceuticals Inc. has a collaboration with Bristol-Myers Squibb Company for the development of Clazakizumab. Alder Biopharmaceuticals Inc. was incorporated in 2002 and is headquartered in Bothell, Washington.
Medicine Biotechnology Health Biopharmaceutical Immunology Antibodies Monoclonal Antibodies Rheumatoid Arthritis Migraine Bristol Myers Squibb Prevention Of Migraine Psoriatic Arthritis
Is ALDR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 18.99
52 Week Low 8.39
Average Volume 3,502,311
200-Day Moving Average 12.5979
50-Day Moving Average 13.8428
20-Day Moving Average 18.8385
10-Day Moving Average 18.892
Average True Range 0.2658
ADX 67.95
+DI 57.1743
-DI 7.8168
Chandelier Exit (Long, 3 ATRs ) 18.1926
Chandelier Exit (Short, 3 ATRs ) 19.3974
Upper Bollinger Band 19.0026
Lower Bollinger Band 18.6744
Percent B (%b) 0.69
BandWidth 1.742177
MACD Line 1.3454
MACD Signal Line 1.6801
MACD Histogram -0.3347
Fundamentals Value
Market Cap 1.28 Billion
Num Shares 67.7 Million
EPS -5.14
Price-to-Earnings (P/E) Ratio -3.68
Price-to-Sales 1026.10
Price-to-Book 2.38
PEG Ratio -0.08
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.98
Resistance 3 (R3) 18.97 18.94 18.96
Resistance 2 (R2) 18.94 18.92 18.94 18.96
Resistance 1 (R1) 18.92 18.91 18.93 18.93 18.95
Pivot Point 18.89 18.89 18.90 18.89 18.89
Support 1 (S1) 18.87 18.87 18.88 18.88 18.85
Support 2 (S2) 18.84 18.86 18.84 18.84
Support 3 (S3) 18.82 18.84 18.84
Support 4 (S4) 18.83